Market Overview The US abetalipoproteinemia monitoring systems market is experiencing access transformation as private payer coverage and reimbursement policies evolve to support rare disease monitoring and management. The US Abetalipoproteinemia Monitoring Systems Market is projected to grow through 2030, driven by the critical importance of insurance coverage for the lifelong, intensive...